Dopamine and light: Dissecting effects on mood and motivational states in women with subsyndromal seasonal affective disorder

Journal of Psychiatry and Neuroscience

Volumn 38, Issue 6, 2013, Pages 388-397

  Cawley, Elizabeth I ^a   Park, Sarah ^a   Rot, Marije Aan Het ^b   Sancton, Kimberley ^a   Benkelfat, Chawki ^a   Young, Simon N ^a   Boivin, Diane B ^a   Leyton, Marco ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c and Applied Physiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DOPAMINE; PHENYLALANINE; PROLACTIN; TYROSINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BEHAVIOR; BODY MASS; DOUBLE BLIND PROCEDURE; ENERGY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIGHT; MOOD; MOOD CHANGE; MOTIVATION; NEUROBIOLOGY; NORMAL HUMAN; PROTEIN CONTENT; PROTEIN INTAKE; PSYCHOLOGIC TEST; QUESTIONNAIRE; SEASONAL AFFECTIVE DISORDER; SLEEP WAKING CYCLE;

ADULT; AFFECT; DOPAMINE; FEMALE; HUMANS; LIGHT; MOTIVATION; PHENYLALANINE; PSYCHOMOTOR PERFORMANCE; REWARD; SEASONAL AFFECTIVE DISORDER; TYROSINE;

EID: 84886715575     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.120181     Document Type: Article

References (63)

1. Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984;41:72-80.
2. Tuunainen A, Kripke DF, Endo T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev 2004;CD004050.
3. Lieverse R, Van Someren EJW, Nielen MMA, et al. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry 2011;68: 61-70.
4. Wirz-Justice A, Bader A, Frisch U, et al. A randomized, doubleblind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry 2011;72:986-93.
5. Janas-Kozik M, Krzystanek M, Stachowicz M, et al. Bright light treatment of depressive symptoms in patients with restrictive type of anorexia nervosa. J Affect Disord 2011;130:462-5.
6. Braun DL, Sunday SR, Fornari VM. Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a doubleblind, placebo-controlled study. Compr Psychiatry 1999;40:442-8.
7. Kasper S, Rogers SL, Yancey A, et al. Phototherapy in individuals with and without subsyndromal seasonal affective disorder. Arch Gen Psychiatry 1989;46:837-44.
8. Avery DH, Kizer D, Bolte MA, et al. Bright light therapy of subsyndromal seasonal affective disorder in the workplace: morning vs. afternoon exposure. Acta Psychiatr Scand 2001;103:267-74.
9. Rosenthal NE, Rotter A, Jacobsen FM, et al. No mood-altering effects found after treatment of normal subjects with bright light in the morning. Psychiatry Res 1987;22:1-9.
10. Lewy AJ, Lefler BJ, Emens JS, et al. The circadian basis of winter depression. Proc Natl Acad Sci U S A 2006;103:7414-9.
11. Jung CM, Khalsa SBS, Scheer FAJL, et al. Acute effects of bright light exposure on cortisol levels. J Biol Rhythms 2010;25:208-16.
12. Scheer FA, Buijs RM. Light affects morning salivary cortisol in humans. J Clin Endocrinol Metab 1999;84:3395-8.
13. Leproult R, Colecchia EF, L'Hermite-Balériaux M, et al. Transition from dim to bright light in the morning induces an immediate elevation of cortisol levels. J Clin Endocrinol Metab 2001;86:151-7.
14. Leproult R, Van Reeth O, Byrne MM, et al. Sleepiness, performance, and neuroendocrine function during sleep deprivation: effects of exposure to bright light or exercise. J Biol Rhythms 1997;12:245-58.
15. White TL, Lejuez CW, de Wit H. Personality and gender differences in effects of d-amphetamine on risk taking. Exp Clin Psycho pharmacol 2007;15:599-609.
16. Young SN, Leyton M. The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav 2002;71:857-65.
17. aan het Rot M, Benkelfat C, Boivin DB, et al. Bright light exposure during acute tryptophan depletion prevents a lowering of mood in mildly seasonal women. Eur Neuropsychopharmacol 2008;18:14-23.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revised. Washington (DC): The Association; 2000.
19. Willner P. Dopamine and depression. In: Di Chiara G, editor. Handbook of experimental pharmacology: dopamine in the CNS. Berlin: Springer; 2002. p. 387-416.
20. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007;64:327-37.
21. Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 2011; 35:537-55.
22. Leyton M. The neurobiology of desire: dopamine and the regulation of mood and motivational states in humans. In: Kringelbach ML, Berridge KC, editors. Pleasures of the brain. New York (NY): Oxford University Press; 2008. p. 222-43.
23. Diehl DJ, Mintun MA, Kupfer DJ, et al. A likely in vivo probe of human circadian timing system function using PET. Biol Psychiatry 1994;36:562-5.
24. Willis GL, Turner EJD. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol Int 2007;24:521-37.
25. Tsai H-Y, Chen KC, Yang YK, et al. Sunshine-exposure variation of human striatal dopamine D2/D3 receptor availability in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:107-10.
26. Neumeister A, Willeit M, Praschak-Rieder N, et al. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med 2001;31:1467-73.
27. Neumeister A, Turner EH, Matthews JR, et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry 1998;55:524-30.
28. Gonzalez MMC, Aston-Jones G. Light deprivation damages mono-amine neurons and produces a depressive behavioral phenotype in rats. Proc Natl Acad Sci U S A 2008;105:4898-903.
29. McTavish SFB, Cowen PJ, Sharp T. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berl) 1999;141:182-8.
30. 11C] raclopride PET study. Am J Psychiatry 2003;160:1887-9.
31. Ruhé HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007;12:331-59.
32. Leyton M, Young SN, Pihl RO, et al. Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsycho-pharmacology 2000;22:52-63.
33. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition. New York (NY): Biometrics Research, New York State Psychiatric Institute; 1997.
34. Rosenthal NE, Bradt GH, Wehr TA. Seasonal Pattern Assessment Questionnaire. Bethesda (MD): National Institute of Mental Health; 1984.
35. Selzer ML, Vinokur A, van Rooijen L. A self-administered Short Michigan Alcoholism Screening Test (SMAST). J Stud Alcohol 1975; 36: 117-26.
36. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
37. Williams JBW. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988;45:742-7.
38. Kasper S, Wehr TA, Bartko JJ, et al. Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry 1989;46:823-33.
39. McTavish SF, Callado L, Cowen PJ, et al. Comparison of the effects of amethyl-p-tyrosine and a tyrosine-free amino acid load on extra cellular noradrenaline in the rat hippocampus in vivo. J Psychopharmacol 1999;13:379-84.
40. McTavish SFB, McPherson MH, Harmer CJ, et al. Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 2001;179:356-60.
41. Benkelfat C, Ellenbogen MA, Dean P, et al. Mood-lowering effect of tryptophan depletion: enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 1994; 51: 687-97.
42. Delgado PL, Charney DS, Price LH, et al. Serotonin function and the mechanism of antidepressant action: reversal of antidepressantinduced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-8.
43. Hernandez S, Vander Wal JS, Spring B. A negative mood induction procedure with efficacy across repeated administrations in women. J Psychopathol Behav Assess 2003;25:49-55.
44. Lorr M, McNair DM, Fisher S. Evidence for bipolar mood states. J Pers Assess 1982;46:432-6.
45. Berridge KC, Robinson TE. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 1998;28:309-69.
46. Lazarus RS. Emotion and adaptation. Oxford: Oxford University Press; 1994.
47. Rolls ET. Emotion explained. Oxford: Oxford University Press; 2005.
48. Roiser JP, McLean A, Ogilvie AD, et al. The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacology 2005;30: 775-85.
49. Barrett SP, Pihl RO, Benkelfat C, et al. The role of dopamine in alcohol self-administration in humans: individual differences. Eur Neuropsychopharmacol 2008;18:439-47.
50. Venugopalan VV, Casey KF, O'Hara C, et al. Acute phenylalanine /tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction. Neuropsychopharmacology 2011;36:2469-76.
51. Salamone JD, Correa M, Farrar AM, et al. Dopamine, behavioral economics, and effort. Front Behav Neurosci 2009;3:13.
52. McTavish SFB, Mannie ZN, Harmer CJ, et al. Lack of effect of tyrosine depletion on mood in recovered depressed women. Neuropsychopharmacology 2005;30:786-91.
53. McLean A, Rubinsztein JS, Robbins TW, et al. The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (Berl) 2004;171:286-97.
54. Aberman JE, Ward SJ, Salamone JD. Effects of dopamine antagon-ists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav 1998;61: 341-8.
55. Leyton M, aan het Rot M, Booij L, et al. Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopa-mine precursor depletion. J Psychiatry Neurosci 2007;32:129-36.
56. Leyton M, Casey KF, Delaney JS, et al. Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion. Behav Neurosci 2005;119:1619-27.
57. Carlsson A, Lindqvist M. Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn Schmiedebergs Arch Pharmacol 1978;303:157-64.
58. Acworth IN, During MJ, Wurtman RJ. Tyrosine: effects on catecholamine release. Brain Res Bull 1988;21:473-7.
59. Liggins J, Pihl RO, Benkelfat C, et al. The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers. PLoS ONE 2012;7:e28370.
60. Le Masurier M, Cowen PJ, Sharp T. Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain. Psychopharmacology (Berl) 2004;171:435-40.
61. Leyton M, Dagher A, Boileau I, et al. Decreasing amphetamineinduced dopamine release by acute phenylalanine/tyrosine depletion: a PET/[11C]raclopride study in healthy men. Neuropsycho-pharmacology 2004;29:427-32.
62. Harmer CJ, McTavish SFB, Clark L, et al. Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl) 2001;154:105-11.
63. Sheehan BD, Tharyan P, McTavish SFB, et al. Use of a dietary manipulation to deplete plasma tyrosine and phenylalanine in healthy subjects. J Psychopharmacol 1996;10:231-4.